Arman Saparov1, Vyacheslav Ogay2, Talgat Nurgozhin3, William C W Chen4,5, Nurlan Mansurov6, Assel Issabekova2, Jamilya Zhakupova3. 1. Department of Biomedical Sciences, Nazarbayev University School of Medicine, Nazarbayev University, Astana, 010000, Kazakhstan. asaparov@nu.edu.kz. 2. Stem Cell Laboratory, National Center for Biotechnology, Astana, 010000, Kazakhstan. 3. Center for Life Sciences, Nazarbayev University, Astana, 010000, Kazakhstan. 4. Research Laboratory of Electronics and Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA. 5. Cardiovascular Research Center, Massachusetts General Hospital, Boston, MA, 02114, USA. 6. Department of Biomedical Sciences, Nazarbayev University School of Medicine, Nazarbayev University, Astana, 010000, Kazakhstan.
Abstract
INTRODUCTION: The immune system plays a crucial role in the initiation, development, and resolution of inflammation following myocardial infarction (MI). The lack of oxygen and nutrients causes the death of cardiomyocytes and leads to the exposure of danger-associated molecular patterns that are recognized by the immune system to initiate inflammation. RESULTS: At the initial stage of post-MI inflammation, the immune system further damages cardiac tissue to clear cell debris. The excessive production of reactive oxygen species (ROS) by immune cells and the inability of the anti-oxidant system to neutralize ROS cause oxidative stress that further aggravates inflammation. On the other hand, the cells of both innate and adaptive immune system and their secreted factors are critically instrumental in the very dynamic and complex processes of regulating inflammation and mediating cardiac repair. CONCLUSIONS: It is important to decipher the balance between detrimental and beneficial effects of the immune system in MI. This enables us to identify better therapeutic targets for reducing the infarct size, sustaining the cardiac function, and minimizing the likelihood of heart failure. This review discusses the role of both innate and adaptive immune systems in cardiac tissue damage and repair in experimental models of MI.
INTRODUCTION: The immune system plays a crucial role in the initiation, development, and resolution of inflammation following myocardial infarction (MI). The lack of oxygen and nutrients causes the death of cardiomyocytes and leads to the exposure of danger-associated molecular patterns that are recognized by the immune system to initiate inflammation. RESULTS: At the initial stage of post-MI inflammation, the immune system further damages cardiac tissue to clear cell debris. The excessive production of reactive oxygen species (ROS) by immune cells and the inability of the anti-oxidant system to neutralize ROS cause oxidative stress that further aggravates inflammation. On the other hand, the cells of both innate and adaptive immune system and their secreted factors are critically instrumental in the very dynamic and complex processes of regulating inflammation and mediating cardiac repair. CONCLUSIONS: It is important to decipher the balance between detrimental and beneficial effects of the immune system in MI. This enables us to identify better therapeutic targets for reducing the infarct size, sustaining the cardiac function, and minimizing the likelihood of heart failure. This review discusses the role of both innate and adaptive immune systems in cardiac tissue damage and repair in experimental models of MI.
Authors: Caterina Curato; Svetlana Slavic; Jun Dong; Anna Skorska; Wassim Altarche-Xifró; Kapka Miteva; Elena Kaschina; Andreas Thiel; Hans Imboden; Jianan Wang; Ulrike Steckelings; Gustav Steinhoff; Thomas Unger; Jun Li Journal: J Immunol Date: 2010-10-08 Impact factor: 5.422
Authors: M Sano; K Fukuda; T Sato; H Kawaguchi; M Suematsu; S Matsuda; S Koyasu; H Matsui; K Yamauchi-Takihara; M Harada; Y Saito; S Ogawa Journal: Circ Res Date: 2001-10-12 Impact factor: 17.367
Authors: Marcin Dobaczewski; Ying Xia; Marcin Bujak; Carlos Gonzalez-Quesada; Nikolaos G Frangogiannis Journal: Am J Pathol Date: 2010-04-09 Impact factor: 4.307
Authors: Gabriel Courties; Timo Heidt; Matthew Sebas; Yoshiko Iwamoto; Derrick Jeon; Jessica Truelove; Benoit Tricot; Greg Wojtkiewicz; Partha Dutta; Hendrik B Sager; Anna Borodovsky; Tatiana Novobrantseva; Boris Klebanov; Kevin Fitzgerald; Daniel G Anderson; Peter Libby; Filip K Swirski; Ralph Weissleder; Matthias Nahrendorf Journal: J Am Coll Cardiol Date: 2013-12-18 Impact factor: 24.094
Authors: Neil Ruparelia; Jernej Godec; Regent Lee; Joshua T Chai; Erica Dall'Armellina; Debra McAndrew; Janet E Digby; J Colin Forfar; Bernard D Prendergast; Rajesh K Kharbanda; Adrian P Banning; Stefan Neubauer; Craig A Lygate; Keith M Channon; Nicholas W Haining; Robin P Choudhury Journal: Eur Heart J Date: 2015-05-16 Impact factor: 29.983
Authors: Rinat Sharir; Jonathan Semo; Sara Shimoni; Tamar Ben-Mordechai; Natalie Landa-Rouben; Sofia Maysel-Auslender; Aviv Shaish; Michal Entin-Meer; Gad Keren; Jacob George Journal: PLoS One Date: 2014-12-01 Impact factor: 3.240
Authors: Alexander R H Hobby; Remus M Berretta; Deborah M Eaton; Hajime Kubo; Eric Feldsott; Yijun Yang; Alaina L Headrick; Keith A Koch; Marcello Rubino; Justin Kurian; Mohsin Khan; Yinfei Tan; Sadia Mohsin; Stefania Gallucci; Timothy A McKinsey; Steven R Houser Journal: Am J Physiol Heart Circ Physiol Date: 2021-08-20 Impact factor: 5.125